OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia
Inés Ibarra‐Lecue, Rebeca Dı́ez-Alarcia, Benito Morentín, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 24

Showing 24 citing articles:

Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?
Yong Weon Yi, Kyu Sic You, Jeong‐Soo Park, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 48-48
Open Access | Times Cited: 73

PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?
Yan Chen, Wei Guan, Meilan Wang, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 2
Open Access | Times Cited: 15

HERV-W Envelope Triggers Abnormal Dopaminergic Neuron Process through DRD2/PP2A/AKT1/GSK3 for Schizophrenia Risk
Qiujin Yan, Xiulin Wu, Ping‐Kun Zhou, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 145-145
Open Access | Times Cited: 28

Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
Valentino Rački, Marina Marcelić, Igor Štimac, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4399-4399
Open Access | Times Cited: 30

mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain
Radhika Chadha, Khaled Alganem, Robert E. McCullumsmith, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6868-6879
Closed Access | Times Cited: 28

Extracellular Matrix Dysfunction Drives Synaptic Pathology in Schizophrenia
Paula Unzueta‐Larrinaga, Esteban Cuesta-Vega, Rocío Barrena-Barbadillo, et al.
Research Square (Research Square) (2025)
Closed Access

The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy
Amany Aa Atia, Rehab H. Ashour, Marwa Maf Zaki, et al.
Psychopharmacology (2023) Vol. 240, Iss. 6, pp. 1313-1332
Open Access | Times Cited: 8

DPYSL2/CRMP2 isoform B knockout in human iPSC-derived glutamatergic neurons confirms its role in mTOR signaling and neurodevelopmental disorders
Kyra L. Feuer, Xi Peng, Christian Yovo, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4353-4362
Open Access | Times Cited: 7

Neuronal alterations in AKT isotype expression in schizophrenia
Emily A. Devine, Ali Sajid Imami, Hunter Eby, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 2

Histopathological evidence of cellular alterations in the dentate gyrus is associated with aberrant RB1CC1-ATG16L1 expression in the hippocampus among older adults with chronic schizophrenia: A pilot post-mortem study
Andreas S. Lappas, Μαρία Ιωάννου, George N. Christodoulou
Schizophrenia Research (2024) Vol. 275, pp. 14-24
Closed Access | Times Cited: 2

Cannabis Use Induces Distinctive Proteomic Alterations in Olfactory Neuroepithelial Cells of Schizophrenia Patients
Marta Barrera, Karina Ausín, Mercedes Lachén‐Montes, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 160-160
Open Access | Times Cited: 13

Dysregulation of DPYSL2 expression by mTOR signaling in schizophrenia: Multi-level study of postmortem brain
Ryuta Izumi, Mizuki Hino, Atsuko Nagaoka, et al.
Neuroscience Research (2021) Vol. 175, pp. 73-81
Open Access | Times Cited: 12

Transcriptomic analyses of rats exposed to chronic mild stress: Modulation by chronic treatment with the antipsychotic drug lurasidone
Veronica Begni, Moira Marizzoni, Kerstin Camile Creutzberg, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 129, pp. 110885-110885
Open Access | Times Cited: 4

Neuronal alterations in AKT isotype expression in schizophrenia
Robert E. McCullumsmith, Ali Sajid Imami, Hunter Eby, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1

His452Tyr polymorphism in the human 5-HT2A receptor affects clozapine-induced signaling networks revealed by quantitative phosphoproteomics
Sandra M. Martín‐Guerrero, Paula Alonso-Batan, Alba Iglesias, et al.
Biochemical Pharmacology (2021) Vol. 185, pp. 114440-114440
Closed Access | Times Cited: 9

GSK3β and mTORC1 Represent 2 Distinct Signaling Markers in Peripheral Blood Mononuclear Cells of Drug-Naive, First Episode of Psychosis Patients
Petros Petrikis, Alexandra Polyzou, Kyriaki Premeti, et al.
Schizophrenia Bulletin (2022) Vol. 48, Iss. 5, pp. 1136-1144
Open Access | Times Cited: 3

Neuronal alterations in AKT isotype expression in schizophrenia
Emily A. Devine, Alex Joyce, Ali Sajid Imami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

P13K/AKT/mTOR Pathway-Based Novel Biomarkers for Breast Cancer
Varruchi Sharma, Anil Panwar, Añil Sharma
Re GEN Open (2021) Vol. 1, Iss. 1, pp. 83-91
Open Access | Times Cited: 3

It takes two to tango: Widening our understanding of the onset of schizophrenia from a neuro-angiogenic perspective
Bárbara S. Casas, David Arancibia-Altamirano, Franco Acevedo-La Rosa, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 2

The biology of schizophrenia as a neurodevelopmental disorder
Amber Berdenis van Berlekom
(2022)
Open Access | Times Cited: 1

Molecular Features Triggered by Antipsychotic Medication in Brain Cells
Lívia Ramos-da-Silva, André Saraiva Leão Marcelo Antunes
Advances in experimental medicine and biology (2022), pp. 65-73
Closed Access | Times Cited: 1

Page 1

Scroll to top